Skip to content
TrialScanner

NCT03978689

A Phase 1 Study in Patients With HPV16+ Recurrent/ Metastatic Head and Neck Squamous Cell Carcinoma

Phase 1CompletedCUELeadMRKCollaborator

Registry record

Lead sponsor
Cue Biopharma
Conditions
Head and Neck Cancer; HPV Positive Oropharyngeal Squamous Cell Carcinoma; HPV-Related Carcinoma
Primary completion
Jan 4, 2026Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT03978689 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT03978689: A Phase 1 Study in Patients... | TrialScanner